Stock Markets February 19, 2026 07:00 AM

EPAM Projects Q1 Results In Line With Estimates as AI-Driven Workload Demand Persists

Software services provider cites sustained client investment in AI and cloud initiatives while posting Q4 beats; shares dip in premarket trading

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
EPAM

EPAM Systems said it expects first-quarter revenue and adjusted earnings per share roughly in line with analyst models, driven by continued customer expenditure on AI-enhanced systems and software projects. The company reported fourth-quarter revenue and adjusted EPS that topped estimates, but its shares fell in premarket trading.

EPAM Projects Q1 Results In Line With Estimates as AI-Driven Workload Demand Persists
EPAM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • EPAM expects Q1 revenue of $1.38 billion to $1.40 billion, with the midpoint matching analyst estimates compiled by LSEG.
  • Adjusted EPS guidance for Q1 is $2.70 to $2.78, also consistent with consensus expectations.
  • EPAM reported Q4 revenue of $1.41 billion and adjusted EPS of $3.26, both above analysts' estimates; shares fell over 4% in premarket trading.

EPAM Systems on Feb. 19 projected first-quarter results consistent with consensus expectations, citing ongoing client investment in AI-enabled systems and continued demand for its software and cloud services. The company delivers a broad suite of IT capabilities, including consulting, cloud and AI transformation, and software engineering, and said these engagements are sustaining its activity levels despite macroeconomic pressures.

For the first quarter, EPAM forecast revenue between $1.38 billion and $1.40 billion. The mid-point of that range aligns with analysts' estimates, according to data compiled by LSEG. On an adjusted basis, the company is guiding profit per share of $2.70 to $2.78, which similarly lines up with consensus expectations.

Looking back at the fourth quarter, EPAM reported revenue of $1.41 billion, which exceeded the analyst estimate of $1.39 billion. Adjusted earnings per share for the quarter came in at $3.26, also above the consensus figure. Despite those quarterly outperformance metrics, the company experienced negative market reaction, with shares falling more than 4% in premarket trading.

The company described client spending patterns as being driven by an imperative to accelerate AI-driven transformation and to modernize software stacks. Even with broader economic uncertainty present, businesses have maintained budgets for software development and AI efforts as they seek to keep pace in the race to deploy advanced capabilities.


Key financial guidance and recent results are as follows:

  • Q1 revenue guidance: $1.38 billion to $1.40 billion; midpoint in line with analysts per LSEG data.
  • Q1 adjusted EPS guidance: $2.70 to $2.78, also in line with estimates.
  • Q4 actuals: revenue $1.41 billion (above $1.39 billion estimate) and adjusted EPS $3.26 (above estimates).
  • Market reaction: shares fell more than 4% in premarket trading following the guidance release.

The guidance and quarter-to-quarter reporting underscore that EPAM's revenue base remains supported by corporate spending on cloud and AI initiatives, even as companies navigate uncertain economic conditions. The company did not provide additional forward-looking details beyond the ranges noted above.

Risks

  • Broader economic uncertainty could pressure future corporate spending on software and transformation projects, impacting IT services demand.
  • Market volatility is evident - EPAM's shares declined more than 4% in premarket trading after the company issued guidance.
  • Continued revenue momentum depends on clients sustaining investment in AI and software modernization initiatives.

More from Stock Markets

American Battery Technology Shares Jump After DOE Restores $115M Grant for Tonopah Flats Refinery Jun 8, 2026 Remy Cointreau Shares Lifted by UBS Upgrade and RC Forward Plan Jun 8, 2026 Campbell’s Shares Jump After Modest Q3 Beat and Intact Guidance Jun 8, 2026 BTIG Strategist Warns of Further Decline for Tech and Chip Stocks Jun 8, 2026 Tango Therapeutics Shares Jump After Strong Pancreatic Cancer Trial Results Jun 8, 2026